LifeMD, Inc. (LFMD)
NASDAQHealth CareMedical - Healthcare Information ServicesSnapshot 2026-09-04
$3.08+0.98%
Close 2026-09-04 · 1-day change
NASDAQHealth CareMedical - Healthcare Information ServicesSnapshot 2026-09-04
QuarterlyIQ Insights · LFMD
What must go right, what could break, what the price assumes, and what evidence comes next.
The current health of the standing investment case.
Recent financial performance sits well below its industry cohort — worth keeping an eye on, though it has not freshly broken.
One-year growth currently built into the price, compared with our model's estimate.
| Measure | Marker shape | Value |
|---|---|---|
| Growth built into the price | circle | -58.0% |
| Our one-year growth estimate | diamond | 20.4% |
Growth built into the price is above our model estimate.
The price assumes 78.4 percentage points less one-year growth.
The one-year revenue growth assumption on Valuation.
For each item: what to watch, what would become a concern, and what would make it less concerning.
A reporting-risk estimate, not a forecast of the stock-price response.
Model as of 2026-09-04 · Compared with 21 industry peers · Company calendar date is not available
LFMD — earnings miss
Dated 2026-05-06
Results of Operations and Financial Condition. On May 6, 2026, LifeMD, Inc. (the “Company”) issued a press release announcing its financial results for the three months ended March 31, 2026. A copy of the press release is furnished herewith as Exhibit 99.1.
Why it matters: More subscribers show strong demand for LifeMD's services. This helps revenue growth.
Supportive ifNet telehealth subscriber growth exceeds 42,000 in Q2.
Worry ifNet subscriber growth falls below 30,000 in Q2.
Why it matters: A positive adjusted EBITDA shows better financial health. This helps build investor trust.
Supportive ifAdjusted EBITDA for Q3 is positive. It is between $1 million and $2 million.
Worry ifAdjusted EBITDA is still negative in Q3.
Why it matters: Using the credit facility well can help growth and boost financial health.
Supportive ifManagement shares a plan to use at least $15M of the credit facility for growth.
Worry ifNo plan or announcement to use the credit facility for growth.
Why it matters: Successful launches can boost growth. They can also lower customer acquisition costs and help revenue.
Supportive ifNew Women’s Health products launched well, leading to better results.
Worry ifNo new products launched or poor performance in Women’s Health metrics.
Why it matters: The partnership could drive new revenue streams and improve market position.
Supportive ifInitial sales from the partnership were better than expected in the first quarter.
Worry ifSales from the partnership did not meet expectations. This shows weak market demand.
Why it matters: Improving trends in this segment could drive overall growth and profitability. It's a key focus area for management.
Supportive ifReported improvement in Women’s Health trends and new product launches in the second half of 2026.
Worry ifNo improvement in Women’s Health metrics or delays in product launches.
Why it matters: This revenue range is key to showing growth momentum in the second half of 2026.
Supportive ifQ3 revenue reported within the range of $48 million to $51 million.
Worry ifQ3 revenue falls below $48 million.
Why it matters: The launch could drive new patient acquisition and revenue growth in the second half.
Supportive ifSuccessful launch of the XYOSTED self-pay program in July 2026.
Worry ifLaunch of the XYOSTED program is delayed or unsuccessful.
Why it matters: More subscribers show that the company is growing in an important area.
Supportive ifWomen’s Health program subscribers increase by 20% or more in Q3.
Worry ifWomen’s Health program subscribers grow less than 20% in Q3.
We watch for confirming and disproving signals on each item. Resolutions are found automatically where possible and checked by hand for unclear cases. Last 90 days shown.
Historical relationships that met the evidence threshold. They do not prove cause or forecast a move.
Usually moved in the same direction.
Price observations: 365 days
Most sensitive to the broad stock market.
Based on historical daily prices through 2026-09-04.
Past price behavior in dollars on a $10,000 position. This does not measure permanent business risk.
How much price usually moves either way.
A larger daily loss that occurred about once in every 20 trading days.
Deepest peak-to-trough drop in the last year.
| Measure | Value | Meaning |
|---|---|---|
| Typical day | ±$291 on $10,000 · ±2.9% | How much price usually moves either way. |
| Bad day | $707 loss on $10,000 · 7.1% | A larger daily loss that occurred about once in every 20 trading days. |
| Largest peak-to-trough drop in the past year | $6,212 loss on $10,000 · 62.1% | Deepest peak-to-trough drop in the last year. |
Past year. 1.00 means similar movement; 1.20 means about 20% more.
Past year. 1.00 means similar movement to the sector. This is secondary context.
Latest 30 trading days, shown as an annual percentage.
Latest 252 trading days, shown as an annual percentage.
20-trading-day average in US dollars.
Trading days used by the source risk snapshot.
Past results, not a forecast. Not investment advice.
Use the underlying financial and sector pages to investigate the cause.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.